Arch Pharmalabs (Usa) Inc. Names Dr. Raj Iyer As President

Arch Pharmalabs Limited, Mumbai, India, announces that effective April 15, 2006, Raj Iyer Ph.D. becomes the President of their US subsidiary, Arch Pharmalabs (USA) Inc. Dr. Iyer will lead Arch’s strategic, commercial and marketing initiatives aimed at the North American pharmaceutical and biotech sectors with a goal of building a world-class provider of active pharmaceutical ingredient and drug intermediate manufacturing services across the product life cycle and creating winning partnerships within these sectors. He will be based in the San Francisco Bay area.